Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001415889-23-004415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-03 | TDOC | GOREVIC JASON N | CEO, Dir | S - Sale | $25.91 | -22.0K | 603.4K | -4% | -$571.1K |
| D | 2023-03-07 | 2023-03-03 | TDOC | GOREVIC JASON N | CEO, Dir | A - Grant | $0.00 | +186.0K | 186.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | S | D | 22,040 | $25.91 | 603,434 | D | — | — | (F1) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. |
| 2 | Derivative | Restricted Stock Units | 2023-03-03 | A | A | 186,012 | $0.00 | 186,012 | D | — · — to — | 186,012 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |